LOVE Act

#7581 | HR Congress #119

Policy Area: Health
Subjects:

Last Action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (2/13/2026)

Bill Text Source: Congress.gov

Summary and Impacts
Original Text

Bill Summary

The "Living Organ Volunteer Engagement Act" (LOVE Act) proposes to amend the Social Security Act to create a demonstration program under Medicare aimed at training facilitators for living kidney donor transplants. This program will be established within 180 days of enactment and will last for eight years.

Here are the key components of the legislation:

1. **Purpose**: The program's primary goal is to train individuals who will assist patients with end-stage renal disease in finding potential living kidney donors and help them navigate the donation process.

2. **Eligible Hospitals**: Only hospitals that perform kidney transplants can participate, and these hospitals will be reimbursed by Medicare for the reasonable costs associated with the training programs.

3. **Reporting Requirements**: The Secretary of Health and Human Services must report to Congress every year, starting six years after the enactment, detailing metrics such as increases in living kidney donors, transplant numbers, patient outcomes, cost savings to Medicare, and qualitative feedback from participants.

4. **Flexibility**: The Secretary has the authority to waive certain provisions to facilitate the program's implementation.

Overall, this legislation aims to improve kidney donation rates and enhance the efficiency of the transplant process, ultimately benefiting patients and reducing costs associated with long-term dialysis treatments.

Possible Impacts

The "Living Organ Volunteer Engagement Act" (LOVE Act) could have several significant impacts on individuals and communities. Here are three examples:

1. **Increased Living Kidney Donations**: By providing funding for living kidney donor transplant facilitator training programs, the legislation aims to educate and empower individuals to assist potential kidney donors. This could lead to an increase in the number of living kidney donations. More trained facilitators can help patients with end-stage renal disease identify suitable donors and navigate the donation process, ultimately improving transplant outcomes and reducing wait times for kidney transplants.

2. **Improved Patient Outcomes**: The act's focus on facilitating the kidney donation process may result in better health outcomes for patients with end-stage renal disease. With trained facilitators assisting patients and their families, individuals may receive timely support and information, leading to more successful transplants. This can decrease reliance on dialysis treatments, which are less effective and more costly over time, improving the overall quality of life for patients.

3. **Cost Savings for Medicare**: The implementation of the demonstration program could yield significant cost savings for the Medicare program. By increasing the number of living donor transplants, the need for expensive dialysis treatments may decline. As the act mandates reporting on cost savings attributable to these changes, it could influence future healthcare spending and resource allocation, benefiting taxpayers and the healthcare system as a whole.

These examples illustrate how the LOVE Act could positively impact individuals in need of kidney transplants, their families, and the broader healthcare system.

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7581 Introduced in House (IH)]

<DOC>






119th CONGRESS
  2d Session
                                H. R. 7581

    To amend title XVIII of the Social Security Act to establish a 
demonstration program to provide payment under the Medicare program for 
          living kidney donor transplant facilitator training.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 13, 2026

    Ms. Malliotakis (for herself and Mr. Gottheimer) introduced the 
   following bill; which was referred to the Committee on Energy and 
  Commerce, and in addition to the Committee on Ways and Means, for a 
 period to be subsequently determined by the Speaker, in each case for 
consideration of such provisions as fall within the jurisdiction of the 
                          committee concerned

_______________________________________________________________________

                                 A BILL


 
    To amend title XVIII of the Social Security Act to establish a 
demonstration program to provide payment under the Medicare program for 
          living kidney donor transplant facilitator training.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Living Organ Volunteer Engagement 
Act'' or the ``LOVE Act''.

SEC. 2. MEDICARE DEMONSTRATION PROGRAM TO PROVIDE PAYMENT FOR LIVING 
              KIDNEY DONOR TRANSPLANT FACILITATOR TRAINING.

    Section 1881 of the Social Security Act (42 U.S.C. 1395rr) is 
amended by adding at the end the following new subsection:
    ``(i) Living Kidney Donor Transplant Facilitator Training 
Demonstration Program.--
            ``(1) In general.--Not later than 180 days after the date 
        of the enactment of this subsection, the Secretary shall 
        establish an 8-year demonstration program under which, for each 
        year of the program, the Secretary shall pay to each eligible 
        hospital participating in the program for such year an amount 
        equal to the reasonable costs of the hospital in operating a 
        living kidney donor transplant facilitator training program 
        described in paragraph (3) for such year, as determined by the 
        Secretary.
            ``(2) Eligible hospital.--A hospital is eligible to 
        participate in the demonstration program under this subsection 
        if such hospital is a hospital in which kidney transplants are 
        performed.
            ``(3) Living kidney donor transplant facilitator training 
        program described.--A living kidney donor transplant 
        facilitator training program described in this paragraph is a 
        program operated by a hospital that trains individuals to--
                    ``(A) assist individuals who are entitled to 
                benefits under parts A and B of this title and have 
                been determined to have end-stage renal disease in 
                identifying prospective living kidney donors; and
                    ``(B) assist individuals entitled to benefits under 
                parts A and B of this title pursuant to subsection (d) 
                in successfully navigating the kidney donation process.
            ``(4) Waiver.--The Secretary may waive such provisions of 
        this title as may be necessary in order to implement the 
        demonstration program.
            ``(5) Reports.--
                    ``(A) Initial report.--Not later than 6 years after 
                the date of the enactment of this subsection, the 
                Secretary shall submit to the appropriate committees of 
                Congress a report that includes, with respect to the 5-
                year period following such date of enactment, the 
                following information:
                            ``(i) Any increase in the number of living 
                        kidney donors, as compared to the 5-year period 
                        preceding such date of enactment.
                            ``(ii) Any increase in the number of 
                        transplants conducted using kidneys donated by 
                        living donors, as compared to the 5-year period 
                        preceding such date of enactment.
                            ``(iii) Outcome measures for individuals 
                        that received kidneys from living donors during 
                        such period.
                            ``(iv) Any cost savings to the Medicare 
                        program attributable to the increase in 
                        transplant services and the decline in dialysis 
                        services, as compared to the 5-year period 
                        preceding such date of enactment.
                            ``(v) Qualitative information with respect 
                        to transplants conducted using kidneys donated 
                        by living donors during such period, as 
                        determined based on interviews of facilitators, 
                        volunteers at eligible hospitals participating 
                        in the demonstration program established under 
                        paragraph (1), living kidney donors, and kidney 
                        transplant recipients.
                    ``(B) Subsequent reports.--Not later than 1 year 
                after the initial report is submitted under 
                subparagraph (A), and annually thereafter for the next 
                2 years, the Secretary shall submit to the appropriate 
                committees of Congress a report that includes updates 
                to the information described in clauses (i) through (v) 
                of such subparagraph.
                    ``(C) Definitions.--In this paragraph:
                            ``(i) Appropriate committees of congress.--
                        The term `appropriate committees of Congress' 
                        means--
                                    ``(I) the Committee on Ways and 
                                Means and the Committee on Energy and 
                                Commerce of the House of 
                                Representatives; and
                                    ``(II) the Committee on Finance of 
                                the Senate.
                            ``(ii) Facilitator.--The term `facilitator' 
                        means an individual who has received training 
                        under a living kidney donor transplant 
                        facilitator training program described in 
                        paragraph (3).''.
                                 <all>